Annandale Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-18,571
| Closed | -$520K | – | 126 |
|
|
2024
Q2 | $520K | Buy |
18,571
+3
| +0% | +$84 | 0.09% | 86 |
|
|
2024
Q1 | $515K | Buy |
18,568
+9,925
| +115% | +$275K | 0.09% | 85 |
|
|
2023
Q4 | $249K | Buy |
8,643
+2,087
| +32% | +$60.1K | 0.05% | 106 |
|
|
2023
Q3 | $217K | Sell |
6,556
-1,449
| -18% | -$48K | 0.05% | 104 |
|
|
2023
Q2 | $294K | Buy |
8,005
+1,885
| +31% | +$69.2K | 0.09% | 103 |
|
|
2023
Q1 | $250K | Sell |
6,120
-102
| -2% | -$4.17K | 0.08% | 106 |
|
|
2022
Q4 | $319K | Sell |
6,222
-187
| -3% | -$9.59K | 0.1% | 99 |
|
|
2022
Q3 | $280K | Buy |
6,409
+2
| +0% | +$87 | 0.1% | 104 |
|
|
2022
Q2 | $336K | Buy |
6,407
+965
| +18% | +$50.6K | 0.13% | 97 |
|
|
2022
Q1 | $282K | Sell |
5,442
-4,725
| -46% | -$245K | 0.11% | 92 |
|
|
2021
Q4 | $600K | Sell |
10,167
-1,326
| -12% | -$78.3K | 0.26% | 67 |
|
|
2021
Q3 | $494K | Sell |
11,493
-302
| -3% | -$13K | 0.3% | 57 |
|
|
2021
Q2 | $462K | Buy |
11,795
+1,102
| +10% | +$43.2K | 0.28% | 60 |
|
|
2021
Q1 | $387K | Sell |
10,693
-283
| -3% | -$10.2K | 0.27% | 48 |
|
|
2020
Q4 | $404K | Buy |
+10,976
| New | +$404K | 0.34% | 36 |
|